Lantern Pharma (LTRN) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.55
-0.46
-0.38
-0.29

Details

Expected EPS
-0.55
Actual EPS
-0.46
Surprise EPS
0.09
Surprise Percent
+16.36%

Description

Lantern Pharma (LTRN) has reported earnings of -0.46 per share for Q3 2024.

0 Comments

Share your thoughts